European Injection Pen Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031

The European injection pen market is anticipated to grow at a CAGR of 7.4% over the forecast period. The key factors that drive the growth of the market in the region include easy availability of these devices in the region owing to the presence of key players such as Sanofi SA, Novo Nordisk AS, F. Hoffmann-La Roche Ltd. among many others which are pioneers in innovation, design, and manufacture of the injection pen.

Some of the instances of the injection pen provided by the companies include the AllStar Pro pen injector which is a reusable pen injector for the drug delivery to the patient. Further, Novo Nordisk's NovoPen 6 and NovoPen Echo Plus are connected pens are reusable and include a tiny screen that displays the last dose that is approved in Europe (CE marked) for the use. Hence, this is likely to drive the growth of the European injection pen industry over the forecast period.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-injection-pen-market

The major countries of Europe including the UK, France, Germany, Italy, Spain, and the Rest of Europe support the market growth. Increasing cases of diabetes in these countries has more individuals taking insulin, which could also be self-taken using an insulin pen. As per the Diabetes UK, in 2019, there were almost 3.7 million people who were diagnosed with diabetes in the country; IDF recorded more than 3 million cases of diabetes in France in 2019; as per a 2019 report by the German Diabetes Center (DDZ), more than 7.2% of the population in Germany suffers from diabetes. Thus, this creates a scope for market growth in the major economies of Europe over the forecast period.

Europe Injection Pen Market - Segmentation

By Type

• Reusable
• Disposable

By Disorder Type

• Autoimmune Disorders
• Hormonal Disorders
• Orphan Diseases
• Others

Europe Injection Pen Market - Countries Covered

• UK
• Germany
• France
• Italy
• Rest of Europe

A full report of European Injection Pen Market is available at: https://www.omrglobal.com/industry-reports/european-injection-pen-market

European Injection Pen Market- Segment by Region

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Company Profiles

• AstraZeneca Plc
• Bayer AG
• Biocorp Production SA
• Eli Lilly and Co.
• Hoffmann-La Roche Ltd.
• Gerresheimer AG
• GlaxoSmithKline Plc
• Haselmeier GmbH
• Merck KGaA
• Mylan N.V.
• Novartis International AG

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.